Pfizer Inc. Profile Avatar - Palmy Investing

Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin f…
Drug Manufacturers - General
US, New York [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
82.23 75.99 77.63 80.79 81.42 80.69 80.25 76.66 78.61 79.03 80.25 79.26 62.08 65.77 50.06
Profit Margin
17.27 12.18 14.84 24.70 42.65 18.42 14.25 13.66 40.55 20.79 31.45 16.75 27.04 31.27 3.62
Operating Margin
31.30 20.88 26.96 30.50 31.73 27.21 26.56 25.99 26.85 28.04 29.25 25.37 30.55 39.90 7.24
EPS Growth
2.50 -16.26 24.27 53.13 64.80 -55.42 -21.53 4.43 202.54 -46.78 53.68 -56.85 213.49 41.52 -93.20
Return on Assets (ROA)
4.05 4.23 5.32 7.84 12.78 5.40 4.16 4.20 12.40 7.00 9.72 4.55 12.11 15.91 0.94
Return on Equity (ROE)
9.59 9.40 12.18 17.93 28.83 12.81 10.75 12.12 29.88 17.59 25.77 11.10 28.47 32.79 2.38
Return on Invested Capital (ROIC)
9.57 9.46 10.27 11.94 10.53 9.31 9.74 11.69 21.49 13.52 12.10 9.81 20.09 27.73 5.39
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
22.85 22.58 20.72 20.16 21.20 21.67 23.28 24.52 24.80 25.88 31.13 24.82 20.39 17.68 31.97
Debt/Equity
54.06 50.14 47.39 46.10 47.82 51.45 60.23 70.68 59.75 65.08 82.58 60.52 47.92 36.45 81.35
Debt/EBITDA
207.36 183.53 121.38 108.09 156.46 173.36 199.72 207.02 203.90 187.40 257.46 259.42 122.85 78.95 685.87
Debt/Capitalization
35.09 33.40 32.15 31.55 32.35 33.97 37.59 41.41 37.40 39.42 45.23 37.70 32.40 26.71 44.86
Interest Debt per Share USD
7.12 5.70 5.20 5.24 5.56 5.99 6.51 7.11 7.35 7.25 9.65 7.15 6.84 6.44 13.25
Debt Growth
181.56 -9.51 -11.55 -3.82 -2.59 0.53 6.26 7.97 1.24 -3.15 26.37 -26.60 -3.33 -5.75 115.20
Liquidity
Current Ratio
165.67 211.36 205.66 214.60 240.71 266.76 149.00 125.18 135.21 156.71 87.93 135.29 139.89 121.65 90.67
Quick Ratio
112.31 150.62 177.63 189.67 178.74 207.07 116.09 93.58 102.75 94.90 58.70 90.34 109.71 88.43 49.94
Cash Ratio
5.31 6.06 12.61 36.30 9.34 15.45 12.38 8.34 4.41 3.58 3.50 6.88 4.56 0.99 5.97
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
71.66 193.68 194.17 160.47 155.47 169.12 128.42 181.76 148.32 149.81 123.37 108.03 340.23 382.41 286.71
Receivables Turnover
315.71 449.69 291.88 273.41 551.29 572.21 450.74 468.88 466.21 470.63 428.82 374.38 516.28 690.55 523.36
Payables Turnover
203.39 404.35 393.25 265.81 296.41 278.40 266.52 271.80 241.41 240.65 242.16 201.72 552.55 504.39 435.37
Asset Turnover
23.48 34.77 35.86 31.75 29.97 29.30 29.17 30.78 30.59 33.65 30.90 27.17 44.79 50.88 25.83
Coverage
Interest Coverage
1,269.34 786.99 1,081.20 1,180.51 1,157.43 992.57 1,082.24 1,157.67 1,110.79 1,143.24 961.69 733.61 1,923.55 3,233.44 178.77
Asset Coverage
200 200 200 300 300 300 200 200 200 200 200 200 300 300 100
Cash Flow Coverage (CFGR)
34.09 26.01 51.97 45.53 48.69 46.03 37.23 37.78 38.66 38.35 24.14 37.63 88.06 83.93 12.01
EBITDA Coverage
1,800 1,200 1,700 1,600 1,500 1,400 1,400 1,600 1,500 1,600 1,200 900 2,200 3,500 400
Dividend Coverage
-100 -100 -100 -200 -300 -100 -100 - - -200 -100 -200 - - -200 -300 - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 200 100
Market Prospects
Dividend Yield
4.59 4.56 3.89 3.69 3.33 3.53 3.67 3.90 3.74 3.28 3.89 4.13 2.64 3.13 5.69
Earnings Yield
7.15 6.19 6.24 8.24 11.12 4.88 3.68 3.85 10.40 4.59 7.87 3.43 6.65 10.92 1.30
Price/Earnings (P/E)
1,398.97 1,615.57 1,601.83 1,214.11 899.19 2,051.42 2,715.31 2,598.48 961.85 2,178.64 1,271.02 2,912.81 1,504.80 915.96 7,666.92
Price/Book (P/B)
134.20 151.91 195.07 217.69 259.28 262.83 292.00 314.86 287.42 383.21 327.56 323.35 428.41 300.39 182.51
Price/Sales (P/S)
241.56 196.73 237.79 299.90 383.55 377.78 386.86 354.92 390.04 452.93 399.68 487.92 406.87 286.41 277.73
Price/Cash Flow (P/CF)
728.29 1,164.64 792.13 1,037.27 1,113.70 1,109.98 1,302.27 1,179.05 1,244.38 1,535.25 1,643.09 1,419.70 1,015.16 981.84 1,867.38
End of PFE's Analysis
CIK: 78003 CUSIP: 717081103 ISIN: US7170811035 LEI: - UEI: MHBQULRMEEJ5
Secondary Listings